We are live on ! Find out more
ICVCFIA

IDG China Venture Capital Fund IV Associates Portfolio holdings

AUM $147M
1-Year Est. Return 20.48%
This Fund
S&P 500
This Quarter Est. Return
+8.06%
1 Year Est. Return
-20.48%
3 Year Est. Return
+59.21%
5 Year Est. Return
-10.77%
10 Year Est. Return
AUM
$408M
AUM Growth
+$4.95M
Cap. Flow
-$2.53M
Cap. Flow %
-0.62%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
PONY
Pony AI Inc
PONY
+$2.53M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 67.74%
2 Technology 32.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PDD icon
1
Pinduoduo
PDD
$127B
$275M 67.48%
2,630,982
PONY
2
Pony AI Inc
PONY
$3.56B
$131M 32.01%
9,893,277
-209,388
-2% -$2.53M
BTDR icon
3
Bitdeer Technologies
BTDR
$2.45B
$1.05M 0.26%
91,308
LITB
4
LightInTheBox
LITB
$56.7M
$1.03M 0.25%
898,969

Similar funds

IDG China Venture Capital Fund IV Associates's Q2 2025 Portfolio in Review

As of Q2 2025, IDG China Venture Capital Fund IV Associates held 4 positions worth $408M, up 1.2% from $403M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. IDG China Venture Capital Fund IV Associates opened no new positions and made no exits, leaving the 4-position portfolio largely intact.

By sector, the portfolio is most concentrated in Consumer Discretionary at 68% of assets, down from 78% a quarter earlier, followed by Technology.

  • IDG China Venture Capital Fund IV Associates's biggest Q2 2025 reduction was Pony AI Inc, cutting an estimated $2.53M.
  • IDG China Venture Capital Fund IV Associates's ten largest holdings make up 100% of its $408M portfolio in Q2 2025.
  • IDG China Venture Capital Fund IV Associates opened 0 new positions and closed 0 in Q2 2025.
  • IDG China Venture Capital Fund IV Associates's portfolio value rose 1.2% quarter-over-quarter to $408M.

Based on IDG China Venture Capital Fund IV Associates's 13F filing for Q2 2025, filed 12 Aug 2025.